Zhihua J. Liu
State Key Laboratory Of Molecular Oncology, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 274 publications
Author Correction: Multimodal analysis of cfDNA methylomes for early detecting esophageal squamous cell carcinoma and precancerous lesions.
Journal: Nature communications
Published: August 25, 2026
Single-cell dissection of persistent tumor antigens in non-responders reveals opportunities for TAA-targeted vaccination after neoadjuvant therapy in esophageal squamous cell carcinoma.
Journal: Journal for immunotherapy of cancer
Published: April 01, 2026
Lung microbiota analysis in early-stage lung adenocarcinoma.
Journal: Microbiology spectrum
Published: March 30, 2026
Lactylation of HIF-1α at K172 drives HIF-1 complex assembly to promote hypoxia-induced immune evasion in esophageal squamous cell carcinoma.
Journal: Cancer letters
Published: January 07, 2026
Engineered migrasomes provide a robust and thermally stable vaccination platform.
Journal: eLife
Published: November 13, 2025
CX3CL1-CX3CR1 signaling orchestrates malignant progression of prostate cancer through luminal progenitor-macrophage crosstalk.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: November 05, 2025
BZW1 Drives Immune Evasion in Lung Adenocarcinoma via Ferroptosis Suppression.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 01, 2025
Early infection post targeted chimeric antigen receptor T-cell therapy in patients with hematologic malignancies: a real-world, single-center, large-scale study.
Journal: Bone marrow transplantation
Published: October 29, 2025
Correction: Dysregulated ceramides metabolism by fatty acid 2-hydroxylase exposes a metabolic vulnerability to target cancer metastasis.
Journal: Signal transduction and targeted therapy
Published: September 07, 2025
IgG-Bridging-Seeded Synergistic Aggregation of SARS-CoV-2 Spikes Underlies Potent Neutralization by a Low-Affinity Antibody.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 04, 2025
Last Updated: 09/26/2026